Related Experiment Videos
Interval between surgery and radiotherapy: effect on local control of soft tissue sarcoma
Matthew T Ballo1, Gunar K Zagars, Janice N Cormier
1Division of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA. mballo@mdanderson.org
Summary
The time between surgery and radiation therapy (RT) for soft tissue sarcoma does not significantly affect local control (LC) rates. Delays in RT should not be considered an independent negative factor for LC in these patients.
Area of Science:
- Oncology
- Radiation Oncology
- Surgical Oncology
Background:
- Soft tissue sarcomas are rare malignancies requiring multimodal treatment.
- Postoperative radiotherapy (RT) is a key component in managing soft tissue sarcomas to improve local control (LC).
- The optimal timing for initiating postoperative RT after surgery remains a subject of clinical investigation.
Purpose of the Study:
- To determine the clinical significance of the interval between surgery and postoperative RT.
- To evaluate the impact of RT timing on local control rates in soft tissue sarcoma patients.
Main Methods:
- Retrospective review of 799 patients with soft tissue sarcoma who received postoperative RT.
- Analysis of the interval between surgery and RT initiation.
- Univariate and multivariate analyses to assess factors influencing local control.
Main Results:
- The 10- and 15-year actuarial local control (LC) rates were 79% and 78%, respectively.
- Factors significantly associated with inferior LC included positive resection margins, recurrent disease treatment, specific tumor locations (head/neck, deep trunk), older age, certain histopathologic subtypes, larger tumor size, lower RT dose, and high histologic grade.
- A delay of >30 days between surgery and RT showed a trend towards decreased LC, but this was not statistically significant (p=0.07).
Conclusions:
- The interval between surgery and postoperative RT did not significantly impact the 10-year LC rate in soft tissue sarcoma patients.
- RT delay should not be considered an independent adverse prognostic factor for LC.
- Treatment intensification may not be necessary solely due to a delay in RT initiation.